Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Acta cir. bras ; 38: e383923, 2023. graf
Article in English | LILACS-Express | LILACS, VETINDEX | ID: biblio-1513538

ABSTRACT

ABSTRACT Purpose: To evaluate the effects of the experimental subcutaneous Walker-256 tumor and L-glutamine supplementation, an antioxidant, on the glomerular morphology of rats. Methods: Twenty Wistar rats were distributed into four groups (n = 5): control (C); control treated with 2% L-glutamine (CG); rats with Walker-256 tumor (WT); and rats with Walker-256 tumor treated with 2% L-glutamine (WTG). Renal histological samples were submitted to periodic acid-Schiff and Masson's Trichrome staining to analyze glomerular density, morphometry of glomerular components and glomerulosclerosis; and to immunohistochemistry for fibroblast growth factor-2 (FGF-2). Results: WT showed 50% reduction in body mass gain and cachexia index > 10%, while WTG demonstrated reduction in cachexia (p < 0.05). WT revealed reduction of glomerular density, increase in the glomerular tuft area, mesangial area, matrix in the glomerular tuft, decrease in the urinary space and synechia, and consequently higher glomerulosclerosis (p < 0.05). L-glutamine supplementation in the WTG improved glomerular density, and reduced glomerular tuft area, urinary space, mesangial area, and glomerulosclerosis compared to WT(p < 0.05). WT showed higher collagen area and FGF-2 expression compared to C (p < 0.05). WTG presented lower collagen fibers and FGF-2 expression compared to WT (p < 0.05). Conclusions: L-glutamine supplementation reduced cachexia and was beneficial for glomerular morphology of the rats, as well as it reduced kidney damage and improved the remaining glomeruli morphology.

2.
Acta cir. bras ; 38: e386723, 2023. tab, graf, ilus
Article in English | LILACS, VETINDEX | ID: biblio-1527586

ABSTRACT

Purpose: To evaluate the long-chain fatty acid and major compounds levels in the feces after prophylactic oral use of Lacticaseibacillus casei in an experimental model of intestinal mucositis. Methods: Fifteen Swiss mice were randomly divided into three groups (n=5/group): The negative or positive control groups (n = 5) received saline orally for 18 days and an the intraperitoneal (i.p.) of saline or 5 Fluorouracil (450 mg/kg) in 15th day, respectability. L. casei group received oral concentration of L. casei (1x109 CFU/mL) for 18 days, the i.p. injection of 5-fluorouracil (450 mg/kg) in 15th days. Tissue samples from colon and each small intestine segment were collected for histopathological analysis. Stool samples were collected. Fecal composition of long-chain fatty acids and sterols were analysed by gas chromatography-mass spectrometry on the 15th and the 18th day. Results: The mucosa layer of all small intestine segments of animals from L. casei showed well preserved epithelium and glands, without necrosis signs, but Goblet cells number decreased. Several long-chain fatty acids and sterols have been identified before and after in the groups. L. casei administration after 5-FU treatment reduced concentrations of linoleic acid (18:2) (p < 0.001) and oleic acid (18:1) (p < 0.001) in feces. Conclusions: L. casei prevented the mucosal damage associated with 5-FU-induced intestinal mucositis reduced long-chain fatty acid levels in the feces.


Subject(s)
Inflammatory Bowel Diseases , Mucositis , Fatty Acids , Lacticaseibacillus casei
3.
J. appl. oral sci ; 27: e20180211, 2019. tab, graf
Article in English | LILACS, BBO | ID: biblio-984568

ABSTRACT

Abstract Objective The aim of this study was to evaluate the effects of gliclazide on oxidative stress, inflammation, and bone loss in an experimental periodontal disease model. Material and Methods Male albino Wistar rats were divided into no ligature, ligature, and ligature with 1, 5, and 10 mg/kg gliclazide groups. Maxillae were fixed and scanned using micro-computed tomography to quantify linear and bone volume/tissue volume (BV/TV) and volumetric bone loss. Histopathological, immunohistochemical and immunofluorescence analyses were conducted to examine matrix metalloproteinase-2 (MMP-2), cyclooxygenase 2 (COX-2), cathepsin K, members of the receptor activator of the nuclear factor kappa-Β ligand (RANKL), receptor activator of nuclear factor kappa-Β (RANK), osteoprotegerin (OPG) pathway, macrophage migration inhibitory factor (MIF), superoxide dismutase-1 (SOD-1), glutathione peroxidase-1 (GPx-1), NFKB p 50 (Cytoplasm), NFKB p50 NLS (nuclear localization signal), PI3 kinase and AKT staining. Myeloperoxidase activity, malondialdehyde and glutathione levels, while interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) levels were evaluated by spectroscopic ultraviolet-visible analysis. A quantitative reverse transcription polymerase chain reaction was used to quantify the gene expression of the nuclear factor kappa B p50 subunit (NF-κB p50), phosphoinositide 3-kinase (PI3k), protein kinase B (AKT), and F4/80. Results Micro-computed tomography showed that the 1 mg/kg gliclazide treatment reduced linear bone loss compared to the ligature, 5 mg/kg gliclazide, and 10 mg/kg gliclazide treatments. All concentrations of gliclazide increased bone volume/tissue volume (BV/TV) compared to the ligature group. Treatment with 1 mg/kg gliclazide reduced myeloperoxidase activity, malondialdehyde, IL-1β, and TNF-α levels (p≤0.05), and resulted in weak staining for COX-2, cathepsin k, MMP-2, RANK, RANKL, SOD-1, GPx-1,MIF and PI3k. In addition, down-regulation of NF-κB p50, PI3k, AKT, and F4/80 were observed, and OPG staining was strong after the 1 mg/kg gliclazide treatment. Conclusions This treatment decreased neutrophil and macrophage migration, decreased the inflammatory response, and decreased bone loss in rats with ligature-induced periodontitis.


Subject(s)
Animals , Male , Periodontitis/drug therapy , Alveolar Bone Loss/drug therapy , Oxidative Stress/drug effects , Gliclazide/pharmacology , Antioxidants/pharmacology , Periodontitis/pathology , Immunohistochemistry , Random Allocation , Reproducibility of Results , Alveolar Bone Loss/pathology , Fluorescent Antibody Technique , Macrophage Migration-Inhibitory Factors/adverse effects , Tumor Necrosis Factor-alpha/analysis , Rats, Wistar , Peroxidase/analysis , Reverse Transcriptase Polymerase Chain Reaction , Matrix Metalloproteinase 2/analysis , Interleukin-1beta/analysis , RANK Ligand/analysis , Receptor Activator of Nuclear Factor-kappa B/analysis , X-Ray Microtomography , Cathepsin K/analysis , Gingiva/pathology , Gingiva/chemistry , Gliclazide/therapeutic use , Glutathione/analysis , Malondialdehyde/analysis , Neutrophils/drug effects , Antioxidants/therapeutic use
4.
Clinics ; 70(2): 136-143, 2/2015. tab, graf
Article in English | LILACS | ID: lil-741419

ABSTRACT

OBJECTIVES: Seeds are excellent sources of proteinase inhibitors, some of which may have satietogenic and slimming actions. We evaluated the effect of a trypsin inhibitor from Tamarindus indica L. seeds on weight gain, food consumption and cholecystokinin levels in Wistar rats. METHODS: A trypsin inhibitor from Tamarindus was isolated using ammonium sulfate (30-60%) following precipitation with acetone and was further isolated with Trypsin-Sepharose affinity chromatography. Analyses were conducted to assess the in vivo digestibility, food intake, body weight evolution and cholecystokinin levels in Wistar rats. Histological analyses of organs and biochemical analyses of sera were performed. RESULTS: The trypsin inhibitor from Tamarindus reduced food consumption, thereby reducing weight gain. The in vivo true digestibility was not significantly different between the control and Tamarindus trypsin inhibitor-treated groups. The trypsin inhibitor from Tamarindus did not cause alterations in biochemical parameters or liver, stomach, intestine or pancreas histology. Rats treated with the trypsin inhibitor showed significantly elevated cholecystokinin levels compared with animals receiving casein or water. CONCLUSION: The results indicate that the isolated trypsin inhibitor from Tamarindus reduces weight gain by reducing food consumption, an effect that may be mediated by increased cholecystokinin. Thus, the potential use of this trypsin inhibitor in obesity prevention and/or treatment should be evaluated. .


Subject(s)
Humans , Escherichia coli Infections/epidemiology , Escherichia coli/enzymology , beta-Lactamases/metabolism , Escherichia coli/pathogenicity , Feces/microbiology
5.
In. Lopes, Ademar; Chammas, Roger; Iyeyasu, Hirofumi. Oncologia para a graduação. São Paulo, Lemar, 3; 2013. p.105-111. (Oncologia para a graduação).
Monography in Portuguese | LILACS | ID: lil-691985
6.
In. Lopes, Ademar; Chammas, Roger; Iyeyasu, Hirofumi. Oncologia para a graduação. São Paulo, Lemar, 3; 2013. p.122-131. (Oncologia para a graduação).
Monography in Portuguese | LILACS | ID: lil-691987
7.
Pesqui. bras. odontopediatria clín. integr ; 9(2): 223-227, maio-ago. 2009.
Article in Portuguese | LILACS, BBO | ID: biblio-873951

ABSTRACT

Objetivo: Avaliar o comportamento da membrana basal em lesões do carcinoma epidermóide oral, relacionando esse comportamento com a classificação clínica TNM, localização anatômica e sobrevida dos pacientes. Método: O estudo foi baseado em uma revisão retrospectiva incluindo a observação histológica de 20 casos de carcinoma epidermóide oral dos arquivos do Laboratório de Patologia do Hospital Estadual Dr. Luis Antônio em Natal, RN, Brasil. Com a análise dos prontuários médicos, foram obtidos os dados referentes à classificação clínica TNM e localização anatômica. A gradação histológica de malignidade foi realizada na área invasiva do tumor por dois patologistas em secções histológicas de 3 micrometros de espessura coradas pela hematoxilina e eosina (HE), para obtenção dos escores histológicos de malignidade, e pelo ácido periódico de Schiff (PAS) para o estudo da membrana basal. Resultados: O principal padrão de marcação da membrana basal foi contínuo, variando entre fraco, moderado e intenso, em lesões com baixo escore de malignidade e principalmente localizadas no lábio com a maioria dos pacientes livres da doença. Em lesões reincidentes principalmente em língua, com alto escore de malignidade, o padrão mais evidente de marcação da membrana basal foi descontínuo ou ausente. Conclusão: Lesões de língua com membrana basal descontínua ou ausente em pacientes com estadiamento clínico TNM III ou IV estão relacionadas com um prognóstico desfavorável, ao contrário, das lesões em lábio com a membrana basal contínua e estadiamento clínico TNM I ou II.


Objective: To evaluate the behavior of the basal membrane in oral squamous cell carcinoma lesions, relating this behavior to the TNM clinical classification, anatomic location and patient survival rate. Method: The study was based on a retrospective review, including the histological examination of 20 oral squamous cell carcinoma cases from the fi les of the Dr. Luis Antonio State Hospital's Pathology Laboratory in the city of Natal, RN, Brazil. Data referring to TNM clinical classification and anatomic location were obtained from the analysis of medical records. The histological grading of malignancy was made by the analysis of 3-micrometrics - thick histological sections stained with hematoxylin and eosin by two pathologists in order to obtain the histological malignancy scores, and by the periodic acid-Schiff (PAS) for the analysis of the basal membrane. Results: The main labeling pattern of the basal membrane was continuous, varying among weak, moderate and severe in lesions with low malignancy scores and were predominantly located in the lower lip in most healthy patients. For the recurrent lesions, mainly located on the tongue, with high malignancy scores, the most evident basal membrane labeling pattern was discontinuous or absent. Conclusion: Tongue lesions with discontinuous or absent basal membrane in patients in the III or IV TNM clinical stages are related to a poor prognosis, unlike lip lesions with continuous basal membrane and classified as I or II TNM clinical stages.


Subject(s)
Humans , Male , Female , Adult , Mouth/injuries , Mouth/pathology , Carcinoma, Squamous Cell , Extracellular Matrix/pathology , Basement Membrane/injuries , Basement Membrane/pathology , Retrospective Studies
8.
Pesqui. bras. odontopediatria clín. integr ; 6(2): 125-130, Mai.-Ago.2006. tab, graf
Article in Portuguese | LILACS, BBO | ID: biblio-853702

ABSTRACT

Objetivo: Correlacionar a classificação TNM com os escores histológicos de malignidade e estes parâmetros com o prognóstico em 38 casos de carcinoma epidermóide oral.Método: Os casos foram selecionados dos arquivos do Hospital Dr. Luiz Antonio, Natal, RN, Brasil. Após a análise dos prontuários foram obtidos os dados relativos à classificação clínica TNM e o prognóstico (seguimento de cinco anos). A classificação morfológica dos casos foi realizada de acordo com o sistema de gradação histológica de malignidade proposto por Bryne (1998). Resultados: Houve correlação significante entre escore histológico de malignidade e o prognóstico em carcinoma epidermóide oral e do estadiamento clínico TNM com o prognóstico. Conclusão: Diante destes resultados concluímos que o estadiamento clínico TNM e agradação histológica de malignidade constituem indicadores de prognóstico importantes do carcinoma epidermóide oral.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/pathology , Histology , Neoplasms/diagnosis , Neoplasms/etiology , Prognosis
9.
Rev. odonto ciênc ; 19(43): 69-78, jan.-mar. 2003. tab
Article in Portuguese | LILACS, BBO | ID: lil-397018

ABSTRACT

A doença da célula da Langerhans é uma desordem de etiologia incerta, caracterizada por um amplo aspecto clínico e comportamento bastante variado. Neste estudo foram analisados 33 casos de pacientes com diagnóstico de Doenca de célula de Langerhans no Hospital Infantil Varela Santiago em Natal, RN-Brasil, entre 1997 e 1999. Deste total, 42,4 por cento dos pacientes manifestaram o Granuloma Eosinofílico Solitário, 33 por cento dos pacientes tinham a Doença de Hand-Schüller- Christian e 24,3 por cento destes pertenciam a forma clínica da Doença de Letterer-Siwe. Do total, 54,5 por cento dos pacientes eram do sexo masculino e 45,5 por cento do feminino, com uma média de idade de 3 anos e 7 meses (variando de 06 meses a 15 anos). Setenta por cento dos pacientes apresentavam envolvimento extra-oral, sendo os ossos do crânio e extremidades inferiores, os sítios mais comuns da doença. O tratamento consistiu primariamente da excisão cirúrgica para pacientes com lesões localizadas e terapia com drogas para aquelas com a Doença de Letterer-Siwe. Nosso estudo demonstrou que a forma clínica mais freqüente foi o Granuloma Eosinofílico Solitário e que pacientes mais jovens com disfunção orgânica têm prognóstico pouco favóravel


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Mouth , Histiocytosis, Langerhans-Cell/surgery , Histiocytosis, Langerhans-Cell/epidemiology , Histiocytosis, Langerhans-Cell/drug therapy
10.
Pesqui. odontol. bras ; 14(1): 79-85, jan.-mar. 2000. tab
Article in Portuguese | LILACS, BBO | ID: lil-262669

ABSTRACT

Foram analisados 100 pacientes HIV+/AIDS no Hospital Giselda Trigueiro - Natal/RN, Brasil no período de 1996-97 quanto a presença de manifestaçöes orais nestes pacientes. Setenta e quatro pacientes eram do sexo masculino e 26 do feminino. A idade média dos pacientes do sexo masculino foi 40 anos, variando de 24 a 67 anos e no feminino 29,8 anos variando de 17 a 48 anos. As manifestaçöes orais mais freqüentes foram candidíase (homens - 79,7 por cento; mulheres - 80,7 por cento), gengivite e periodontite (homens - 79,7 por cento; mulheres - 73,0), leucoplasia pilosa (homens - 6,7 por cento; mulheres - 3,8 por cento), herpes labial (homens - 5,4 por cento; mulheres - 7,6 por cento), sarcoma de Kaposi (homens - 6,7 por cento). Verificou-se que 62,2 por cento dos homens eram homo- ou bissexuais e 100 por cento das mulheres eram heterossexuais. Nosso resultados revelaram semelhanças com outros trabalhos realizados em pacientes de outras regiöes do mundo


Subject(s)
Humans , Male , Female , Adult , Acquired Immunodeficiency Syndrome , Mouth Diseases , Oral Manifestations
SELECTION OF CITATIONS
SEARCH DETAIL